James P. Boylan

Insider Reports History

Location
Menlo Park, CA
Signature
/s/ Josh Mandel-Brehm, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by James P. Boylan:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Compass Therapeutics, Inc. Director Stock Option (Right to Buy) 40K 11 Feb 2025 Direct
Immunome Inc. Director Director Stock Option (right to buy) 18.9K 10 Jun 2025 Direct
Zenas BioPharma, Inc. Director Stock Option (Right to Buy) 18.5K 10 Jun 2025 Direct
Immunome Inc. Director Stock option (right to buy) 11.3K 13 Jun 2024 Direct
Camp4 Therapeutics Corp Director Stock Option (Right to Buy) 9K 25 Jun 2025 Direct

Insider Reports Filed by James P. Boylan

Symbol Company Period Transactions Value $ Form Type Role Filing Time
CAMP Camp4 Therapeutics Corp 25 Jun 2025 1 $0 4 Director 27 Jun 2025, 16:03
IMNM Immunome Inc. 10 Jun 2025 1 $0 4 Director 12 Jun 2025, 17:00
ZBIO Zenas BioPharma, Inc. 10 Jun 2025 1 $0 4 Director 12 Jun 2025, 16:36
CMPX Compass Therapeutics, Inc. 11 Feb 2025 1 $0 4 Director 13 Feb 2025, 17:05
CAMP Camp4 Therapeutics Corp 10 Oct 2024 0 $0 3 Director 10 Oct 2024, 21:00
ZBIO Zenas BioPharma, Inc. 12 Sep 2024 1 $0 4 Director 16 Sep 2024, 20:55
ZBIO Zenas BioPharma, Inc. 12 Sep 2024 0 $0 3 Director 12 Sep 2024, 21:37
IMNM Immunome Inc. 13 Jun 2024 1 $0 4 Director 18 Jun 2024, 21:01
CMPX Compass Therapeutics, Inc. 08 Mar 2024 1 $0 4 Director 11 Mar 2024, 10:12
IMNM Immunome Inc. 27 Oct 2023 1 $0 4 Director 31 Oct 2023, 18:32
IMNM Immunome Inc. 02 Oct 2023 0 $0 3 Director 12 Oct 2023, 16:46
CMPX Compass Therapeutics, Inc. 04 Nov 2022 0 $0 3 Director 10 Nov 2022, 18:13